263 related articles for article (PubMed ID: 23873839)
1. Synthesis and biological evaluation of a novel series of 6,8-dibromo-4(3H)quinazolinone derivatives as anticancer agents.
Ahmed MF; Youns M
Arch Pharm (Weinheim); 2013 Aug; 346(8):610-7. PubMed ID: 23873839
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular modelling and biological evaluation of 4-amino-2(1H)-quinazolinone and 2,4(1H,3H)-quinazolidone derivatives as antitumor agents.
Richter S; Gioffreda B
Arch Pharm (Weinheim); 2011 Dec; 344(12):810-20. PubMed ID: 21987492
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.
Ahmed MF; Belal A
Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702
[TBL] [Abstract][Full Text] [Related]
5. Parallel solution phase synthesis of 3,6,7-4(3H)-quinazolinones and evaluation of their antitumor activities against human cancer.
Wu H; Xie X; Liu G
J Comb Chem; 2010 May; 12(3):346-55. PubMed ID: 20196566
[TBL] [Abstract][Full Text] [Related]
6. [Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives bearing dithiocarbamate chains].
Cao SL; Jiang YY; Feng YP; Liu SY; Gao HH; Zhang M; Wan R
Yao Xue Xue Bao; 2007 Jul; 42(7):741-6. PubMed ID: 17882958
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Apoptotic New Quinazolinone-Based Compound and Identification of its Underlying Mitochondrial Signalling Pathway in Breast Cancer Cells.
Zahedifard M; Faraj FL; Paydar M; Looi CY; Hasandarvish P; Hajrezaie M; Kamalidehghan B; Majid NA; Khalifa SA; Ali HM; Abdulla MA; El-Seedi HR
Curr Pharm Des; 2015; 21(23):3417-26. PubMed ID: 25808938
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of some novel quinazolinone derivatives as potent apoptotic inducers.
Nowar RM; A Osman EE; Abou-Seri SM; El Moghazy SM; Abou El Ella DA
Future Med Chem; 2018 May; 10(10):1191-1205. PubMed ID: 29749767
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase.
Babu YR; Bhagavanraju M; Reddy GD; Peters GJ; Prasad VV
Arch Pharm (Weinheim); 2014 Sep; 347(9):624-34. PubMed ID: 24866341
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.
Al-Rashood ST; Aboldahab IA; Nagi MN; Abouzeid LA; Abdel-Aziz AA; Abdel-Hamide SG; Youssef KM; Al-Obaid AM; El-Subbagh HI
Bioorg Med Chem; 2006 Dec; 14(24):8608-21. PubMed ID: 16971132
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents.
Abd El Hamid MK; Mihovilovic MD; El-Nassan HB
Eur J Med Chem; 2012 Nov; 57():323-8. PubMed ID: 23085106
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
Mahdavi M; Pedrood K; Safavi M; Saeedi M; Pordeli M; Ardestani SK; Emami S; Adib M; Foroumadi A; Shafiee A
Eur J Med Chem; 2015 May; 95():492-9. PubMed ID: 25847767
[TBL] [Abstract][Full Text] [Related]
13. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.
Kamal A; Vijaya Bharathi E; Janaki Ramaiah M; Dastagiri D; Surendranadha Reddy J; Viswanath A; Sultana F; Pushpavalli SN; Pal-Bhadra M; Srivastava HK; Narahari Sastry G; Juvekar A; Sen S; Zingde S
Bioorg Med Chem; 2010 Jan; 18(2):526-42. PubMed ID: 20031423
[TBL] [Abstract][Full Text] [Related]
14. Novel thiophene derivatives with sulfonamide, isoxazole, benzothiazole, quinoline and anthracene moieties as potential anticancer agents.
Ghorab MM; Bashandy MS; Alsaid MS
Acta Pharm; 2014 Dec; 64(4):419-31. PubMed ID: 25531783
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anticancer activity evaluation of some novel pyrrolo[1,2-a]azepine derivatives.
Belal A
Arch Pharm (Weinheim); 2014 Jul; 347(7):515-22. PubMed ID: 24729464
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains.
Cao SL; Feng YP; Jiang YY; Liu SY; Ding GY; Li RT
Bioorg Med Chem Lett; 2005 Apr; 15(7):1915-7. PubMed ID: 15780632
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, In Silico and In Vitro Assessment of New Quinazolinones as Anticancer Agents via Potential AKT Inhibition.
Noser AA; El-Naggar M; Donia T; Abdelmonsef AH
Molecules; 2020 Oct; 25(20):. PubMed ID: 33080996
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines.
Aziz MW; Kamal AM; Mohamed KO; Elgendy AA
Bioorg Med Chem Lett; 2021 Jun; 41():127987. PubMed ID: 33771586
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
